DJIA 17,031.14 43.63 0.26%
NASDAQ 4,518.90 -48.70 -1.07%
S&P 500 1,984.13 -1.41 -0.07%
market minute promo

Alkermes, Inc. (NASDAQ: ALKS)

43.68 -0.67 (-1.51%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ALKS $43.68 -1.51%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $44.40
Previous Close $44.35
Daily Range $43.50 - $44.50
52-Week Range $29.36 - $54.25
Market Cap $6.4B
P/E Ratio -1,478.33
Dividend (Yield) $0.00 (0.0%)
Volume 758,366
Average Daily Volume 728,426
Current FY EPS -$0.25

Sector

Healthcare

Industry

Drugs

Alkermes, Inc. (ALKS) Description

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Website: http://www.alkermes.com/

News & Commentary

Is Alkermes plc Stock Undervalued?

Strong science and underserved markets can fuel further gains from this delivery-focused biopharma

First Week of October 18th Options Trading For Alkermes (ALKS)

Alkermes Completes Enrolment for Phase II ALKS 3831 Study - Analyst Blog

Credit Suisseā€™s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014

Alkermes Announces Completion Of Patient Enrollment In Phase 2 Study Of ALKS 3831, A Novel, Broad-Sp

Alkermes Announces Completion Of Patient Enrollment In Phase 2 Study Of ALKS 3831, A Novel, Broad-Spectrum Oral Antipsychotic

Alkermes Gains on Aripiprazole Lauroxil NDA Submission - Analyst Blog

Sector Update: Health-Care Shares Flat Pre-Market

Sector Update: Health Care

US Stock Futures Rise Ahead Of Economic Data

Thursday's ETF Movers: BBH, GXC

Morgan Stanley Sees EPS Below Consensus, Robust Pipeline For Alkermes plc

See More ALKS News...

ALKS's Top Competitors

ALKS $43.68 (-1.51%)
Current stock: ALKS
AMGN $137.97 (0.06%)
Current stock: AMGN
GILD $100.99 (-2.58%)
Current stock: GILD
CELG $89.46 (-2.25%)
Current stock: CELG